| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/18/1994 | CA2111644A1 Use of thrombin inhibitors for the inhibition of ocular fibrin formation |
| 06/17/1994 | CA2111656A1 Variants of corticosteroid binding globulin |
| 06/17/1994 | CA2111454A1 Retroviral protease inhibitors |
| 06/17/1994 | CA2085924A1 Putative therapeutic targets for the prevention and stoppage of human alzheimer's disease: cdna and amino acid sequence of a proteinase/esterase-like protein and a proteinase/protamine, truncated, modified form of the protein, anti ense to the alzheimer elated human app gene |
| 06/16/1994 | DE4241490A1 Brain natriuretic peptide for treating lung and bronchial diseases - more effective at bronchodilation than urodilatin used at the same doses |
| 06/15/1994 | EP0602004A1 Peptides having T cell helper activity |
| 06/15/1994 | EP0602003A1 Peptides having T cell helper activity |
| 06/15/1994 | EP0601859A2 Pharmaceutic composition comprising cancer-related antibodies |
| 06/15/1994 | EP0601799A1 Sustained-release preparation |
| 06/15/1994 | EP0601486A1 Cis-epoxide derivatives useful as irreversible HIV protease inhibitors and process and intermediates for their preparation |
| 06/15/1994 | EP0601459A2 Sulfonamido heterocyclic thrombin inhibitors |
| 06/15/1994 | EP0601360A1 Progenitor B cell stimulating factor |
| 06/15/1994 | EP0601187A1 Novel antibiotic and production and use thereof |
| 06/15/1994 | EP0601183A1 Anti-hiv drug |
| 06/15/1994 | EP0601135A1 Osteogenic proteins in the treatment of bone diseases |
| 06/15/1994 | EP0601129A1 Morphogenic protein screening method |
| 06/15/1994 | EP0601125A1 V$g(a)12.1 T-CELL RECEPTOR-SPECIFIC REAGENTS FOR DIAGNOSING AND TREATING RHEUMATOID ARTHRITIS |
| 06/15/1994 | EP0601106A1 Morphogen-induced modulation of inflammatory response |
| 06/15/1994 | EP0601053A1 Compositions and methods for the sublingual or buccal administration of therapeutic agents |
| 06/15/1994 | EP0601043A1 Hybrid cytokines |
| 06/15/1994 | EP0600974A1 Preparation of medicaments containing the peptidoglycan monomer or its derivatives |
| 06/15/1994 | EP0600970A1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 06/15/1994 | EP0600930A1 Diagnosis and treatment of autoimmune diseases |
| 06/15/1994 | EP0600880A1 INTERLEUKIN 1$g(b) PROTEASE AND INTERLEUKIN 1$g(b) PROTEASE INHIBITORS |
| 06/15/1994 | EP0600875A1 Purification of recombinant apolipoprotein e from bacteria |
| 06/15/1994 | EP0600869A1 Synthetic peptides for arterial imaging |
| 06/15/1994 | EP0600868A1 Recombinantly produced lipases for therapeutical treatment |
| 06/15/1994 | EP0469045B1 SYNTHETIC $i(PSEUDOMONAS) $i(AERUGINOSA) PILIN PEPTIDE AND RELATED VACCINES AND DIAGNOSTICS |
| 06/15/1994 | EP0469017B1 Expression of human apolipoproteins ai-milano in yeast |
| 06/15/1994 | EP0441832B1 Composition and treatment with biologically active peptides and certain anions |
| 06/15/1994 | EP0401379B1 STABILIZED COMPOSITION OF INTERLEUKIN-1$g(b) |
| 06/15/1994 | CN1087916A Glycosilated cytokines |
| 06/15/1994 | CN1087902A Morpholine and thiomorpholine tachykinin receptor antagonists |
| 06/15/1994 | CN1087829A Composition and method of treating hepatitis B |
| 06/15/1994 | CA2110854A1 Antiviral antibiotic bu-4628v and preparation thereof |
| 06/15/1994 | CA2110827A1 Antiviral antibiotic bu-4724v and preparation thereof |
| 06/14/1994 | US5321127 Antiplatelet and antithrombotic activity of platelet glycoprotein Ib receptor fragments |
| 06/14/1994 | US5321126 Method of preparing a fibrinogen concentrate from blood plasma |
| 06/14/1994 | US5321123 Protein S polypeptides and anti-peptide antibodies that inhibit protein S binding to C4B binding protein, diagnostic systems and therapeutic methods |
| 06/14/1994 | US5321032 Peptide compounds and pharmaceutical compositions thereof |
| 06/14/1994 | US5321030 Administering for treatment or prevention |
| 06/14/1994 | US5321010 Proteins for inhibiting adhesion of platelets to collagen |
| 06/14/1994 | US5321009 Administering rapamycin |
| 06/14/1994 | US5321008 Administering an insulin and a calcitonin |
| 06/14/1994 | US5320962 DNA encoding the human A1 adenosine receptor |
| 06/14/1994 | US5320956 Ovarian, esophageal and cervical carcinomas |
| 06/14/1994 | US5320950 DNA encoding anticoagulative protein PP4-X, and its preparation and use |
| 06/14/1994 | US5320942 Detecting pancreatic cells |
| 06/14/1994 | US5320941 DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom |
| 06/14/1994 | US5320840 Continuous release pharmaceutical compositions |
| 06/12/1994 | CA2110672A1 Spiro peperidines and holologs which promote release of growth hormone |
| 06/10/1994 | CA2110543A1 Peg hydrazone and peg oxime linkage forming reagents and protein derivatives thereof |
| 06/09/1994 | WO1994012876A1 Allergen/inflammatory testing and diagnosis |
| 06/09/1994 | WO1994012661A1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody |
| 06/09/1994 | WO1994012650A2 Activating expression of an amplifying endogenous gene by homologous recombination |
| 06/09/1994 | WO1994012649A2 Gene therapy for cystic fibrosis |
| 06/09/1994 | WO1994012648A2 Method for producing soluble t-receptors by co-transfection, and use of resulting products |
| 06/09/1994 | WO1994012639A2 Interleukin-3 (il-3) mutant polypeptides |
| 06/09/1994 | WO1994012638A2 Interleukin-3 (il-3) multiple mutation polypeptides |
| 06/09/1994 | WO1994012637A2 Novel human amyloid protein precursor homologue and kunitz-type inhibitors |
| 06/09/1994 | WO1994012635A2 Novel seven transmembrane receptors |
| 06/09/1994 | WO1994012634A1 Neurotrophic factor |
| 06/09/1994 | WO1994012631A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 06/09/1994 | WO1994012628A1 Cloning and expression of biologically active alpha-galactosidase a |
| 06/09/1994 | WO1994012625A2 LIGAND BINDING VARIABLE DOMAIN (V-MIN) COMPRISING A FRAMEWORK REGION WITH A CYCLICALLY PERMUTED CENTRAL β-BARREL |
| 06/09/1994 | WO1994012539A1 Multifunctional neurotrophic factors |
| 06/09/1994 | WO1994012537A2 Granulocyte chemotactic protein |
| 06/09/1994 | WO1994012535A1 Progenitor b cell stimulating factor |
| 06/09/1994 | WO1994012534A2 Melanogenic inhibitor, and methods of producing and using the same |
| 06/09/1994 | WO1994012533A1 Gp41 mutants and their use as hiv therapeutics |
| 06/09/1994 | WO1994012532A1 New oligopeptides with affinity to opioid receptors |
| 06/09/1994 | WO1994012531A1 Antagonists of human gamma interferon |
| 06/09/1994 | WO1994012530A1 Polyunsaturated fatty acyl-peptide composition |
| 06/09/1994 | WO1994012529A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
| 06/09/1994 | WO1994012528A1 Subtilin variant of enhanced stability and activity |
| 06/09/1994 | WO1994012527A1 Therapeutic compounds suitable for the treatment of diseases connected with glutathione deficiency, process for their preparation, and pharmaceutical compositions containing same |
| 06/09/1994 | WO1994012524A1 Protein hydrolysate derived from mucosal tissue |
| 06/09/1994 | WO1994012521A1 Cellular genes encoding retinoblastoma-associated proteins |
| 06/09/1994 | WO1994012513A1 Aids therapeutics based on hiv ma peptides |
| 06/09/1994 | WO1994012217A1 Cyclodextrin and polymer based drug delivery system |
| 06/09/1994 | WO1994012215A1 Humanized antibodies reactive with l-selectin |
| 06/09/1994 | WO1994012214A1 Humanized antibodies reactive with cd18 |
| 06/09/1994 | WO1994012210A1 Anti-edlf antibody, composition thereof and method of diagnosing and treating cardiac arrhythmias, hypertension |
| 06/09/1994 | WO1994012209A1 Malignant cell growth regulation by common acute lymphoblastic leukemia antigen |
| 06/09/1994 | WO1994012208A1 Process for producing plasminogen-containing composition |
| 06/09/1994 | WO1994012206A1 Treatment of dermatological malignancies with biologically active peptides |
| 06/09/1994 | WO1994012204A1 Anticoagulant proteins |
| 06/09/1994 | WO1994012203A1 DRUGS CONTAINING reg PROTEIN AS ACTIVE INGREDIENT |
| 06/09/1994 | WO1994012202A1 ACTIVATION OF p53 PROTEIN |
| 06/09/1994 | WO1994012201A1 Use of fibroblast growth factors as neuroprotective and neuromodulatory agents |
| 06/09/1994 | WO1994012199A1 Purified coriolus versicolor polypeptide complex |
| 06/09/1994 | WO1994012196A1 Conjugates and constructs including anti-cd28 and anti-cd3 binding molecules |
| 06/09/1994 | WO1994012170A2 Polyunsaturated fatty acid based drugs, in particular docosahexaenoic acid, for use as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain |
| 06/09/1994 | WO1994012162A1 Syndecan stimulation of cellular differentiation |
| 06/09/1994 | WO1994012158A1 Controlled release growth hormone containing microspheres |
| 06/09/1994 | WO1994012150A1 Mouthcare compositions |
| 06/09/1994 | WO1994012144A2 Treatment of infertility and enhancement of fertilization capacity in mammalian males |
| 06/09/1994 | WO1994006913A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 06/09/1994 | WO1994004565A3 Ipnv vaccine |
| 06/09/1994 | WO1994004180A3 Novel uses of il-4 and/or il-10, and antibodies against the same |